118 related articles for article (PubMed ID: 32988808)
1. Oxidative-protective effect of nuclear receptor coactivator 7 on arecoline-induced endothelial-to-mesenchymal transition.
Wang Y; Luo D; Yuan X; Luo Y; Cheng X; Gao Y; Xie X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):565-573. PubMed ID: 32988808
[TBL] [Abstract][Full Text] [Related]
2. YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis.
Li J; Yao M; Zhu X; Li Q; He J; Chen L; Wang W; Zhu C; Shen T; Cao R; Fang C
J Dent Res; 2019 Jul; 98(8):920-929. PubMed ID: 31282845
[TBL] [Abstract][Full Text] [Related]
3. Hemeoxygenase-1 expression in response to arecoline-induced oxidative stress in human umbilical vein endothelial cells.
Hung TC; Huang LW; Su SJ; Hsieh BS; Cheng HL; Hu YC; Chen YH; Hwang CC; Chang KL
Int J Cardiol; 2011 Sep; 151(2):187-94. PubMed ID: 21889036
[TBL] [Abstract][Full Text] [Related]
4. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
Lee SS; Chen YJ; Tsai CH; Huang FM; Chang YC
Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
[TBL] [Abstract][Full Text] [Related]
5. Role of autophagy induced by arecoline in angiogenesis of oral submucous fibrosis.
Dai Z; Zhu B; Yu H; Jian X; Peng J; Fang C; Wu Y
Arch Oral Biol; 2019 Jun; 102():7-15. PubMed ID: 30951892
[TBL] [Abstract][Full Text] [Related]
6. Role of the arecoline/YAP1/BMP4 pathway in promoting endothelial-mesenchymal transition in oral submucous fibrosis.
Yao M; Li J; Yuan S; Zhu X; Hu Z; Li Q; Cao R; Wang W; Fang C
J Oral Pathol Med; 2020 Apr; 49(4):305-310. PubMed ID: 31397922
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
8. Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
Hsieh YP; Wu KJ; Chen HM; Deng YT
J Formos Med Assoc; 2018 Jun; 117(6):527-534. PubMed ID: 28720506
[TBL] [Abstract][Full Text] [Related]
9. Augmented heme oxygenase-1 expression in areca quid chewing-associated oral submucous fibrosis.
Tsai CH; Yang SF; Lee SS; Chang YC
Oral Dis; 2009 May; 15(4):281-6. PubMed ID: 19388153
[TBL] [Abstract][Full Text] [Related]
10. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
11. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
12. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chou MY; Chang YC
Oral Oncol; 2003 Jun; 39(4):367-72. PubMed ID: 12676256
[TBL] [Abstract][Full Text] [Related]
13. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
14. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
[TBL] [Abstract][Full Text] [Related]
15. Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis.
Khan I; Kumar N; Pant I; Narra S; Kondaiah P
PLoS One; 2012; 7(12):e51806. PubMed ID: 23284772
[TBL] [Abstract][Full Text] [Related]
16. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis.
Tsai CH; Chou MY; Chang YC
J Oral Pathol Med; 2003 Mar; 32(3):146-53. PubMed ID: 12581384
[TBL] [Abstract][Full Text] [Related]
17. miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis.
Zheng L; Jian X; Guo F; Li N; Jiang C; Yin P; Min AJ; Huang L
Oncol Rep; 2015 Jun; 33(6):2753-60. PubMed ID: 25872484
[TBL] [Abstract][Full Text] [Related]
18. Epithelial atrophy in oral submucous fibrosis is mediated by copper (II) and arecoline of areca nut.
Khan I; Pant I; Narra S; Radhesh R; Ranganathan K; Rao SG; Kondaiah P
J Cell Mol Med; 2015 Oct; 19(10):2397-412. PubMed ID: 26248978
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin (1-7) inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation.
You Y; Huang Y; Wang D; Li Y; Wang G; Jin S; Zhu X; Wu B; Du X; Li X
J Cell Physiol; 2019 Apr; 234(4):4668-4680. PubMed ID: 30246378
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
Tsai CH; Lee SS; Chang YC
J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]